(Q37634417)

21 August 2017

0 references

1 reference

title

Statins in the management of patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis (English)

1 reference

aneurysmal subarachnoid hemorrhage

21 August 2017

0 references

0 references

1 reference

1 reference

Andreas H Kramer

1

1 reference

PubMed ID

19921470

21 August 2017

Jeffrey J Fletcher

series ordinal

2

1 reference

21 August 2017

1 April 2010

1 reference

21 August 2017

1 reference

21 August 2017

12

1 reference

21 August 2017

2

1 reference

21 August 2017

285-296

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-009-9306-9

21 August 2017

0 references

cites work

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9306-9

Evaluating non-randomised intervention studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9306-9

Prediction of delayed cerebral ischemia, rebleeding, and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9306-9

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9306-9

SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-009-9306-9

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial

1 reference

12 December 2020

Role of statins in cerebral vasospasm

1 reference

12 December 2020

Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis

1 reference

12 December 2020

Metaanalysis of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

12 December 2020

A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study

1 reference

12 December 2020

Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association

1 reference

12 December 2020

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

12 December 2020

Simvastatin for the prevention of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage: a single-institution prospective cohort study

1 reference

12 December 2020

The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results

1 reference

12 December 2020

Statins may not protect against vasospasm in subarachnoid haemorrhage.

1 reference

12 December 2020

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

1 reference

12 December 2020

Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study

1 reference

12 December 2020

Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.

1 reference

12 December 2020

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

12 December 2020

Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm?

1 reference

12 December 2020

Prehemorrhage statin use and the risk of vasospasm after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

A case control study of statin and magnesium administration in patients after aneurysmal subarachnoid hemorrhage: incidence of delayed cerebral ischemia and mortality

1 reference

12 December 2020

Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial

1 reference

12 December 2020

Calcium antagonists for aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

Statin use was not associated with less vasospasm or improved outcome after subarachnoid hemorrhage

1 reference

12 December 2020

Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial

1 reference

12 December 2020

10.1007/S12028-009-9306-9

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19921470